The Lancet Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 33.7 | Q1 | 97.6% | 9.432 | Q1 | 99.7% |
| 2024 | 35.9 | Q1 | 97.9% | 11.319 | Q1 | 99.8% |
| 2023 | 41.6 | Q1 | 97.6% | 12.179 | Q1 | 99.8% |
| 2022 | 51.1 | Q1 | 98.8% | 12.270 | Q1 | 99.8% |
| 2021 | 54.4 | Q1 | 98.7% | 11.710 | Q1 | 99.8% |
| 2020 | — | — | 13.530 | Q1 | 99.9% | |
| 2019 | — | — | 15.650 | Q1 | 99.9% | |
| 2018 | — | — | 18.073 | Q1 | 99.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1474-5488
ISSN
1470-2045
region
Western Europe
coverage
2000-2026